Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.

There are three major requirements for a nanoparticle to deliver its payload to the tumor. First, the particles need to be stable in the circulation without releasing the drug prematurely. Second, the nanoparticles accumulate in the tumor efficiently. Third, the drug is released locally in the tumor tissue or inside the tumor cells. A variety of approaches have been developed to fulfill these requirements. In this perspective, we will discuss them together with some examples.

[1]  F. Bates,et al.  Polymer vesicles in vivo: correlations with PEG molecular weight. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Leaf Huang,et al.  Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.

[3]  J. Morgenstern Perspectives and future directions. , 2007, Alcoholism, clinical and experimental research.

[4]  Yun Chen,et al.  Tumor-targeted delivery of siRNA by self-assembled nanoparticles. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Michael J Sailor,et al.  Biomimetic amplification of nanoparticle homing to tumors , 2007, Proceedings of the National Academy of Sciences.

[6]  P. Oh,et al.  Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung , 2007, Nature Biotechnology.

[7]  Leaf Huang,et al.  An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[8]  T. Park,et al.  Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Chun Wang,et al.  Well-defined block copolymers for gene delivery to dendritic cells: probing the effect of polycation chain-length. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Kinam Park To PEGylate or not to PEGylate, that is not the question. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[11]  P. Cullis,et al.  Stabilized Plasmid–Lipid Particles: Pharmacokinetics and Plasmid Delivery to Distal Tumors following Intravenous Injection , 2000, Journal of drug targeting.

[12]  Leaf Huang,et al.  Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[13]  N. Yamazaki,et al.  CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.